Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

Anti-SARS-CoV-2 antibodies were present in the majority of COVID-19 patient samplesRBD- and S-specific IgG levels remained stable up to 6 months after diagnosisSpecific memory B and T cells developed in >95% of COVID-19 patientsMemory B and T cell responses were maintained at least 6–8 months after infection